Adma Biologics (ADMA) Payables (2011 - 2026)
Adma Biologics (ADMA) reported Payables of $35.66 million for Q3 2026, up 48.5% from $24.02 million a year earlier and up 12.4% from the prior quarter.
Analysis
Adma Biologics (ADMA) Payables (2011 - 2026) Analysis & Trends
At the end of FY2025, Adma Biologics posted Payables of $22.52 million, up 11.4% from FY2024.
- Payables has increased for seven consecutive years, with a five-year compound annual growth rate of 15.3% (FY2020 to FY2025).
- By year, Payables came in at $20.22 million in FY2024 (+29.1%), $15.66 million in FY2023 (+18.4%), $13.23 million in FY2022 (+6.4%) and $12.43 million in FY2021 (+12.2%).
- The Q3 2026 figure ranks as the highest quarterly Payables in data going back to Q4 2011.
- Year over year, Payables gained in seven of the last eight quarters, with growth averaging 34.4%.
- The high point for year-over-year Payables in five years was Q2 2025 (growth of 110.0%); the low point was Q3 2023 (a decline of 56.9%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $31.72 million (Q2 2026), $20.52 million (Q1 2026) and $22.52 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 35.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 35.66 Mn |
| Jun 30, 2026 | 31.72 Mn |
| Mar 31, 2026 | 20.52 Mn |
| Dec 31, 2025 | 22.52 Mn |
| Sep 30, 2025 | 24.02 Mn |
| Jun 30, 2025 | 29.77 Mn |
| Mar 31, 2025 | 20.61 Mn |
| Dec 31, 2024 | 20.22 Mn |
| Sep 30, 2024 | 16.02 Mn |
| Jun 30, 2024 | 14.18 Mn |
| Mar 31, 2024 | 17.19 Mn |
| Dec 31, 2023 | 15.66 Mn |
| Sep 30, 2023 | 10.85 Mn |
| Jun 30, 2023 | 12.08 Mn |
| Mar 31, 2023 | 12.96 Mn |
| Dec 31, 2022 | 13.23 Mn |
| Sep 30, 2022 | 25.20 Mn |
| Jun 30, 2022 | 11.39 Mn |
| Mar 31, 2022 | 14.12 Mn |
| Dec 31, 2021 | 12.43 Mn |
API Access
Adma Biologics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ADMA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();